<!DOCTYPE html>



<html lang="en">



	<meta charset="UTF-8">

	<meta name="viewport" content="width=device-width, initial-scale=1.0">

	<style>


    .node {

        stroke: #fff;

        stroke-width: 2px;

    }

    

    .link {

        stroke: #777;

        stroke-width: 2px;

    }



</style>

<body>

<a href="https://riskrunners.com">Home</a><br>




<a href="#risk_factors">Jump to Risk Factors</a><br>



<a href="#industry">Jump to Industries</a><br>


<a href="#exposure">Jump to Exposures</a><br>


<a href="#event_code">Jump to Event Codes</a><br>


<a href="#wiki">Jump to Wiki Summary</a><br><br>


    <script src="https://d3js.org/d3.v3.min.js"></script>

    <script>


// set a width and height for our SVG

var width = 3000,


    height = 3000;

    
// setup links

var links =     [
{source: "START_HERE", target: "1: following important factors", fill: "#8e4585"},
{source: "1: following important factors", target: "1: materially", fill: "#8e4585"},
{source: "1: materially", target: "1: company may", fill: "#8e4585"},
{source: "1: following important factors", target: "2: processes over billing", fill: "#fbceb1"},
{source: "2: processes over billing", target: "2: deterioration", fill: "#fbceb1"},
{source: "2: deterioration", target: "2: financial condition", fill: "#fbceb1"},
{source: "2: financial condition", target: "2: payors could", fill: "#fbceb1"},
{source: "2: payors could", target: "2: significant negative", fill: "#fbceb1"},
{source: "2: significant negative", target: "2: impact on", fill: "#fbceb1"},
{source: "2: impact on", target: "2: operations", fill: "#fbceb1"},
{source: "2: processes over billing", target: "3: collection", fill: "#ffff31"},
{source: "3: collection", target: "3: accounts", fill: "#ffff31"},
{source: "3: accounts", target: "3: significant", fill: "#ffff31"},
{source: "3: significant", target: "3: challenges", fill: "#ffff31"},
{source: "3: challenges", target: "3: constant focus", fill: "#ffff31"},
{source: "3: constant focus", target: "3: involvement by", fill: "#ffff31"},
{source: "3: involvement by", target: "3: management", fill: "#ffff31"},
{source: "3: management", target: "3: ongoing enhancements", fill: "#ffff31"},
{source: "3: collection", target: "4: payors andor patients", fill: "#85bb65"},
{source: "4: payors andor patients", target: "4: financial difficulties", fill: "#85bb65"},
{source: "4: financial difficulties", target: "4: may otherwise", fill: "#85bb65"},
{source: "4: may otherwise", target: "4: pay accounts", fill: "#85bb65"},
{source: "4: pay accounts", target: "4: increased writeoffs", fill: "#85bb65"},
{source: "4: payors andor patients", target: "5: current levels", fill: "#e0b0ff"},
{source: "5: current levels", target: "5: collectibility", fill: "#e0b0ff"},
{source: "5: collectibility", target: "5: future periods", fill: "#e0b0ff"},
{source: "5: current levels", target: "6: properly bill", fill: "#6ca0dc"},
{source: "6: properly bill", target: "6: accounts receivable", fill: "#6ca0dc"},
{source: "6: accounts receivable", target: "6: adversely affected", fill: "#6ca0dc"},
{source: "6: properly bill", target: "10: approximately", fill: "#f8de7e"},
{source: "10: approximately", target: "10: incremental", fill: "#f8de7e"},
{source: "10: approximately", target: "14: began adopting alternative pricing", fill: "#d9603b"},
{source: "14: began adopting alternative pricing", target: "14: methodologies", fill: "#d9603b"},
{source: "14: methodologies", target: "14: certain drugs", fill: "#d9603b"},
{source: "14: certain drugs", target: "14: biologicals under", fill: "#d9603b"},
{source: "14: began adopting alternative pricing", target: "15: reimbursement", fill: "#4b3621"},
{source: "15: reimbursement", target: "15: corresponding offset", fill: "#4b3621"},
{source: "15: corresponding offset", target: "15: service costs incurred", fill: "#4b3621"},
{source: "15: reimbursement", target: "21: Operating Systems and ControlsAprias ", fill: "#1034a6"},
{source: "21: Operating Systems and ControlsAprias ", target: "21: successfully", fill: "#1034a6"},
{source: "21: successfully", target: "21: system modifications designed", fill: "#1034a6"},
{source: "21: system modifications designed", target: "21: maximize productivity", fill: "#1034a6"},
{source: "21: maximize productivity", target: "21: significant negative impact on", fill: "#1034a6"},
{source: "21: significant negative impact on", target: "21: operations", fill: "#1034a6"},
{source: "21: operations", target: "21: financial condition", fill: "#1034a6"},
{source: "21: Operating Systems and ControlsAprias ", target: "22: management", fill: "#ffc40c"},
{source: "22: management", target: "22: areas throughout", fill: "#ffc40c"},
{source: "22: areas throughout", target: "22: operations", fill: "#ffc40c"},
{source: "22: operations", target: "22: current processes", fill: "#ffc40c"},
{source: "22: current processes", target: "22: higher level", fill: "#ffc40c"},
{source: "22: higher level", target: "22: productivity", fill: "#ffc40c"},
{source: "22: management", target: "23: ultimate cost savings", fill: "#eb4c42"},
{source: "23: ultimate cost savings", target: "23: successful design", fill: "#eb4c42"},
{source: "23: successful design", target: "23: implementation", fill: "#eb4c42"},
{source: "23: implementation", target: "23: such initiatives", fill: "#eb4c42"},
{source: "23: such initiatives", target: "23: necessary", fill: "#eb4c42"},
{source: "23: necessary", target: "23: help offset", fill: "#eb4c42"},
{source: "23: help offset", target: "23: reimbursement", fill: "#eb4c42"},
{source: "23: reimbursement", target: "23: reductions", fill: "#eb4c42"},
{source: "23: reductions", target: "23: continued downward pressure on pricing", fill: "#eb4c42"},
{source: "23: ultimate cost savings", target: "24: successfully", fill: "#c154c1"},
{source: "24: successfully", target: "24: modifications", fill: "#c154c1"},
{source: "24: modifications", target: "24: productivity improvements could", fill: "#c154c1"},
{source: "24: productivity improvements could", target: "24: significant impact on", fill: "#c154c1"},
{source: "24: significant impact on", target: "24: operations", fill: "#c154c1"},
{source: "24: operations", target: "24: financial condition", fill: "#c154c1"},
{source: "24: successfully", target: "27: stringent laws", fill: "#fc8eac"},
{source: "27: stringent laws", target: "27: regulations at both", fill: "#fc8eac"},
{source: "27: regulations at both", target: "27: compliance with burdensome", fill: "#fc8eac"},
{source: "27: compliance with burdensome", target: "27: complex billing", fill: "#fc8eac"},
{source: "27: complex billing", target: "27: substantiation", fill: "#fc8eac"},
{source: "27: substantiation", target: "27: recordkeeping requirements", fill: "#fc8eac"},
{source: "27: stringent laws", target: "28: Financial ", fill: "#e25822"},
{source: "28: Financial ", target: "28: relationships", fill: "#e25822"},
{source: "28: relationships", target: "28: referral sources", fill: "#e25822"},
{source: "28: referral sources", target: "28: strict limitations", fill: "#e25822"},
{source: "28: Financial ", target: "29: addition strict licensing", fill: "#f0ead6"},
{source: "29: addition strict licensing", target: "29: safety requirements", fill: "#f0ead6"},
{source: "29: safety requirements", target: "29: services pharmaceuticals", fill: "#f0ead6"},
{source: "29: addition strict licensing", target: "30: Violations ", fill: "#417dc1"},
{source: "30: Violations ", target: "30: regulations", fill: "#417dc1"},
{source: "30: regulations", target: "30: facility", fill: "#417dc1"},
{source: "30: facility", target: "30: participation", fill: "#417dc1"},
{source: "30: participation", target: "30: Medicare and Medicaid", fill: "#417dc1"},
{source: "30: Violations ", target: "31: Government ", fill: "#779ecb"},
{source: "31: Government ", target: "31: public will continue", fill: "#779ecb"},
{source: "31: public will continue", target: "31: debate healthcare reform", fill: "#779ecb"},
{source: "31: Government ", target: "32: Changes ", fill: "#c08081"},
{source: "32: Changes ", target: "32: interpretations", fill: "#c08081"},
{source: "32: interpretations", target: "32: methodology", fill: "#c08081"},
{source: "32: methodology", target: "32: operations", fill: "#c08081"},
{source: "32: Changes ", target: "34: current market continues", fill: "#fc8eac"},
{source: "34: current market continues", target: "34: exert pressure on healthcare companies", fill: "#fc8eac"},
{source: "34: exert pressure on healthcare companies", target: "34: reduce healthcare costs", fill: "#fc8eac"},
{source: "34: reduce healthcare costs", target: "34: reduced margins", fill: "#fc8eac"},
{source: "34: reduced margins", target: "34: home healthcare", fill: "#fc8eac"},
{source: "34: home healthcare", target: "34: providers such as", fill: "#fc8eac"},
{source: "34: current market continues", target: "36: These ", fill: "#0038a8"},
{source: "36: These ", target: "36: managed care organizations which control", fill: "#0038a8"},
{source: "36: managed care organizations which control", target: "36: healthcare economy", fill: "#0038a8"},
{source: "36: These ", target: "40: healthcare providers", fill: "#ffdab9"},
{source: "40: healthcare providers", target: "40: industrial gas manufacturers", fill: "#ffdab9"},
{source: "40: industrial gas manufacturers", target: "40: hospital systems home health agencies", fill: "#ffdab9"},
{source: "40: hospital systems home health agencies", target: "40: health maintenance", fill: "#ffdab9"},
{source: "40: health maintenance", target: "40: organizations", fill: "#ffdab9"},
{source: "40: organizations", target: "40: may continue", fill: "#ffdab9"},
{source: "40: may continue", target: "40: various service lines", fill: "#ffdab9"},
{source: "40: healthcare providers", target: "41: competitors", fill: "#a2add0"},
{source: "41: competitors", target: "41: significantly", fill: "#a2add0"},
{source: "41: competitors", target: "START_HERE", fill: "#a2add0"}]; 
    // create empty nodes array
    var nodes = {};
	var colorFill = [];
	
    // compute nodes from links data
    links.forEach(function(link) {
        link.source = nodes[link.source] ||
            (nodes[link.source] = {name: link.source});
        link.target = nodes[link.target] ||
            (nodes[link.target] = {name: link.target});
		colorFill.push({name: link.source.name, fill: link.fill });
		colorFill.push({name: link.target.name, fill: link.fill });
    });
	
	console.log(colorFill);


    // add a SVG to the body for our viz
    var svg=d3.select('body').append('svg')
        .attr("viewBox", "0 0 " + width + " " + height );

    // use the force
    var force = d3.layout.force()
		.charge(-5000)
		.gravity(0.3)
        .size([width, height])
        .nodes(d3.values(nodes))
        .links(links)
        .on("tick", tick)
        .linkDistance(200)
        .start();

    // add links
    var link = svg.selectAll('.link')
        .data(links)
        .enter().append('line')
        .attr('class', 'link'); 

    // add nodes
    var node = svg.selectAll('.node')
        .data(force.nodes())
        .enter().append('circle')
        .attr('class', 'node')
        .attr('r', width * 0.0035)
		.style("fill", function(d) {
									for (var i = 0; i < colorFill.length; i++) {
										//console.log(d.name);
										if(colorFill[i].name == d.name){
											console.log(colorFill[i].fill);
											return colorFill[i].fill;
										}
									} return "#555";
									
									});
	var label = svg.selectAll(null)
		.data(force.nodes())
		.enter()
		.append("text")
		.text(function (d) { return d.name; })
		.style("text-anchor", "middle")
		.style("fill", "#555")
		.style("font-family", "Arial")
		.style("font-size", 34);


    // what to do 
    function tick(e) {
        
        node.attr('cx', function(d) { return d.x = Math.max(6, Math.min(width - 6, d.x)); })
            .attr('cy', function(d) { return d.y = Math.max(6, Math.min(height - 6, d.y)); })
            .call(force.drag);
            
        link.attr('x1', function(d) { return d.source.x; })
            .attr('y1', function(d) { return d.source.y; })
            .attr('x2', function(d) { return d.target.x; })
            .attr('y2', function(d) { return d.target.y; });
		
		label.attr("x", function(d){ return d.x; })
             .attr("y", function (d) {return d.y - 10; });
        
    }
    
</script><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='industry'>Industries</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Asset Management and Custody Banks</td>
    </tr>
    <tr>
      <td>Diversified Financial Services</td>
    </tr>
  </tbody>
</table><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='exposure'>Exposures</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Political reform</td>
    </tr>
    <tr>
      <td>Military</td>
    </tr>
    <tr>
      <td>Express intent</td>
    </tr>
    <tr>
      <td>Provide</td>
    </tr>
    <tr>
      <td>Regime</td>
    </tr>
    <tr>
      <td>Economic</td>
    </tr>
    <tr>
      <td>Cooperate</td>
    </tr>
  </tbody>
</table><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='event_code'>Event Codes</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Adjust</td>
    </tr>
    <tr>
      <td>Solicit support</td>
    </tr>
    <tr>
      <td>Offer peace proposal</td>
    </tr>
    <tr>
      <td>Warn</td>
    </tr>
    <tr>
      <td>Promise policy support</td>
    </tr>
    <tr>
      <td>Release or return</td>
    </tr>
    <tr>
      <td>Sanction</td>
    </tr>
    <tr>
      <td>Force</td>
    </tr>
    <tr>
      <td>Promise</td>
    </tr>
    <tr>
      <td>Yield to order</td>
    </tr>
    <tr>
      <td>Host meeting</td>
    </tr>
  </tbody>
</table><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='wiki'>Wiki</th>
      <th>Wiki Summary</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Transcription_factor">Transcription factor</a></td>
      <td>In molecular biology, a transcription factor (TF) (or sequence-specific DNA-binding factor) is a protein that controls the rate of transcription of genetic information from DNA to messenger RNA, by binding to a specific DNA sequence. The function of TFs is to regulate—turn on and off—genes in order to make sure that they are expressed in the desired cells at the right time and in the right amount throughout the life of the cell and the organism.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Composite_material">Composite material</a></td>
      <td>A composite material (also called a composition material or shortened to composite, which is the common name) is a material which is produced from two or more constituent materials. These constituent materials have notably dissimilar chemical or physical properties and are merged to create a material with properties unlike the individual elements.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Contact_Telecom">Contact Telecom</a></td>
      <td>Contact Telecom is a telecommunications and IT services company that develops data processing and software services for the telecommunications industry, established in 1998.\nBased in Manchester, New Hampshire, Contact Telecom offers carriers, service providers, telecommunication companies, Internet service providers, wireless, voice over IP, competitive local exchange carriers, incumbent local exchange carriers, cable companies and cloud computing providers a way to manage their invoice and usage data through cost management, revenue assurance and customer care initiatives.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Sonic's_Ultimate_Genesis_Collection">Sonic's Ultimate Genesis Collection</a></td>
      <td>Sonic's Ultimate Genesis Collection (Sega Mega Drive Ultimate Collection in PAL regions) is a compilation of video games developed by Backbone Entertainment and published by Sega for PlayStation 3 and Xbox 360. The compilation features 48 Sega games (49 counting two versions of Altered Beast) which were previously released for the Sega Genesis (including most of the Sonic the Hedgehog titles released for the system), arcades and the Master System.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/The_Challenge_(TV_series)">The Challenge (TV series)</a></td>
      <td>The Challenge (originally known as Road Rules: All Stars, followed by Real World/Road Rules Challenge) is a reality competition show on MTV that is spun off from two of the network's reality shows, The Real World and Road Rules. Originally featuring alumni from these two shows, casting for The Challenge has slowly expanded to include contestants who debuted on The Challenge itself, alumni from other MTV franchises including Are You the One?, Ex on the Beach (Brazil, UK and US), Geordie Shore and from other non-MTV shows.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Dandelin_spheres">Dandelin spheres</a></td>
      <td>In geometry, the Dandelin spheres are one or two spheres that are tangent both to a plane and to a cone that intersects the plane. The intersection of the cone and the plane is a conic section, and the point at which either sphere touches the plane is a focus of the conic section, so the Dandelin spheres are also sometimes called focal spheres.The Dandelin spheres were discovered in 1822.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Collecting_the_Kid">Collecting the Kid</a></td>
      <td>Collecting the Kid is a compilation album by El-P. It was released through Definitive Jux on October 19, 2004.The album is not intended as a direct follow-up to Fantastic Damage, but instead collects together various B-sides, instrumentals, film soundtracking work, and beats El-P has previously produced for other artists.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Bill_Belichick">Bill Belichick</a></td>
      <td>William Stephen Belichick (; born April 16, 1952) is an American professional football coach who is the head coach of the New England Patriots of the National Football League (NFL). He exercises extensive authority over the Patriots' football operations, effectively making him the team's general manager as well.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Silk_Road_(marketplace)">Silk Road (marketplace)</a></td>
      <td>Silk Road was an online black market and the first modern darknet market. As part of the dark web, it was operated as a Tor hidden service, such that online users were able to browse it anonymously and securely without potential traffic monitoring.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Incremental_dating">Incremental dating</a></td>
      <td>Incremental dating techniques allow the construction of year-by-year annual chronologies, which can be temporally fixed (i.e., linked to the present day and thus calendar or sidereal time) or floating.\nArchaeologists use tree-ring dating (dendrochronology) to determine the age of old pieces of wood.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Japanese_asset_price_bubble">Japanese asset price bubble</a></td>
      <td>The Japanese asset price bubble (バブル景気, baburu keiki, "bubble economy") was an economic bubble in Japan from 1986 to 1991 in which real estate and stock market prices were greatly inflated. In early 1992, this price bubble burst and Japan's economy stagnated.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Decolonizing_Methodologies">Decolonizing Methodologies</a></td>
      <td>Decolonizing Methodologies: Research and Indigenous Peoples is a book by Linda Tuhiwai Smith. Originally published in 1999, Decolonizing Methodologies is a seminal text in indigenous studies that explores the intersections of colonialism and research methodologies.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Myalgia">Myalgia</a></td>
      <td>Myalgia (also called muscle pain and muscle ache in layman's terms) is the medical term for muscle pain.  Myalgia is a symptom of many diseases.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Restrictions_on_geographic_data_in_China">Restrictions on geographic data in China</a></td>
      <td>Under Chinese law, the use of geographic information in the People's Republic of China is restricted to entities that have special authorization from the administrative department for surveying and mapping under the State Council. Consequences of the restriction include fines for unauthorized surveys, lack of geotagging information on many cameras when the GPS chip detects a location within China, incorrect alignment of street maps with satellite maps in various applications, and the criminalization of crowdsourced mapping efforts such as OpenStreetMap.Chinese lawmakers said that these restrictions are to "safeguard the security of China's geographic information".</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Carrier_frequency_offset">Carrier frequency offset</a></td>
      <td>Carrier frequency offset (CFO) is one of many non-ideal conditions that may affect in baseband receiver design. In designing a baseband receiver, we should notice not only the degradation invoked by non-ideal channel and noise, we should also regard RF and analog parts as the main consideration.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/List_of_most_successful_German_U-boats">List of most successful German U-boats</a></td>
      <td>List of successful U-boats contains lists of the most successful German U-boats in the two World Wars based on total tonnage.\n\n\n== World War I ==\nThis list contains the 5 most successful German U-boats during the First World War based on total tonnage.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Periodic_counter-current_chromatography">Periodic counter-current chromatography</a></td>
      <td>Periodic counter-current chromatography (PCC) is a method for running affinity chromatography in a quasi-continuous manner. Today, the process is mainly employed for the purification of antibodies in the biopharmaceutical industry as well as in research and development.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Vision_City_(Rwanda)">Vision City (Rwanda)</a></td>
      <td>Vision City is multi-phase housing development in Kigali, Rwanda currently being built by Ultimate Developers LTD for the Rwanda Social Security Board. At 4500 units and a total cost of 150 million USD it is the largest residential housing project in the country's history.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Instructional_design">Instructional design</a></td>
      <td>Instructional design (ID), also known as instructional systems design (ISD), is the practice of systematically designing, developing and delivering instructional materials and experiences, both digital and physical, in a consistent and reliable fashion toward an efficient, effective, appealing, engaging and inspiring acquisition of knowledge. The process consists broadly of determining the state and needs of the learner, defining the end goal of instruction, and creating some "intervention" to assist in the transition.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Boeing_X-51_Waverider">Boeing X-51 Waverider</a></td>
      <td>The Boeing X-51 Waverider is an unmanned research scramjet experimental aircraft for hypersonic flight at Mach 5 (3,300 mph; 5,300 km/h) and an altitude of 70,000 feet (21,000 m). The aircraft was designated X-51 in 2005.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Body_modification">Body modification</a></td>
      <td>Body modification (or body alteration) is the deliberate altering of the human anatomy or human physical appearance.  In its broadest definition it includes skin tattooing, socially acceptable decoration (e.g., common ear piercing in many societies), and religious rites of passage (e.g., circumcision in a number of cultures), as well as the modern primitive movement.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Mining_engineering">Mining engineering</a></td>
      <td>Mining in the engineering discipline is the extraction of minerals from underneath, open pit, above or on the ground. Mining engineering is associated with many other disciplines, such as mineral processing, exploration, excavation, geology, and metallurgy, geotechnical engineering and surveying.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Patriot_Act">Patriot Act</a></td>
      <td>The USA PATRIOT Act (commonly known as the Patriot Act) was a landmark Act of the United States Congress, signed into law by President George W. Bush. The formal name of the statute is the Uniting and Strengthening America by Providing Appropriate Tools Required to Intercept and Obstruct Terrorism (USA PATRIOT) Act of 2001, and the commonly used short name is a contrived acronym that is embedded in the name set forth in the statute.The Patriot Act was enacted following the September 11 attacks and the 2001 anthrax attacks with the stated goal of dramatically tightening U.S. national security, particularly as it related to foreign terrorism.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Financial_crisis_of_2007–2008">Financial crisis of 2007–2008</a></td>
      <td>The financial crisis of 2008, or Global Financial Crisis, was a severe worldwide economic crisis that occurred in the early 21st century. It was the most serious financial crisis since the Great Depression (1929).</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Financialization">Financialization</a></td>
      <td>Financialization (or financialisation in British English) is a term sometimes used to describe the development of financial capitalism during the period from 1980 to present, in which debt-to-equity ratios increased and financial services accounted for an increasing share of national income relative to other sectors.\nFinancialization describes an economic process by which exchange is facilitated through the intermediation of financial instruments.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Recruitment">Recruitment</a></td>
      <td>Recruitment refers to the overall process of identifying, sourcing, screening, shortlisting, and interviewing candidates for jobs (either permanent or temporary) within an organization. Recruitment can also refer to the processes involved in choosing individuals for unpaid roles.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/ISO_10218">ISO 10218</a></td>
      <td>ISO 10218 Robots and robotic devices — Safety requirements for industrial robots is an international standard for industrial robot safety, developed by ISO/TC 184/SC 2 "Robots and robotic devices" in parallel with the European Committee for Standardization. It consists of two parts:\n\nPart 1: Robots\nPart 2: Robot systems and integrationAs a European standard it has the designation EN ISO 10218-1 and -2 (not to be mixed with EN 10218).ISO/TS 15066 was published in 2016 to address the new field of safety requirements for cobots.Revisions to the original standard have been planned by the ISO/TC 299 committee.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Diversified_Pharmaceutical_Services">Diversified Pharmaceutical Services</a></td>
      <td>Diversified Pharmaceutical Services entered the market in 1976 as the pharmacy benefit manager for United HealthCare, a leading managed care organization. It pioneered many cost containment strategies that are now core pharmacy benefit manager services and became a recognized leader in clinical programs.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Queen's_Regulations">Queen's Regulations</a></td>
      <td>The Queen's Regulations (first published in 1731 and known as the King's Regulations when the monarch is a king) is a collection of orders and regulations in force in the Royal Navy, British Army, Royal Air Force, and Commonwealth Realm Forces (where the same person as on the British throne is also their separate head of state), forming guidance for officers of these armed services in all matters of discipline and personal conduct. Originally, a single set of regulations were published in one volume.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Federal_government_of_the_United_States">Federal government of the United States</a></td>
      <td>The federal government of the United States (U.S. federal government or U.S. government) is the national government of the United States, a federal republic in North America, composed of 50 states, a city within a federal district (the city of Washington in the District of Columbia, where the entire federal government is based), five major self-governing territories and several island possessions. The federal government is composed of three distinct branches: legislative, executive, and judicial, whose powers are vested by the U.S. Constitution in the Congress, the president and the federal courts, respectively.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Public_relations">Public relations</a></td>
      <td>Public relations (PR) is the practice of managing and disseminating information from an individual or an organization (such as a business, government agency, or a nonprofit organization) to the public in order to affect their public perception. Public relations (PR) and publicity differ in that PR is controlled internally, whereas publicity is not controlled and contributed by external parties.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Many-worlds_interpretation">Many-worlds interpretation</a></td>
      <td>The many-worlds interpretation (MWI) is an interpretation of quantum mechanics that asserts that the universal wavefunction is objectively real, and that there is no wave function collapse. This implies that all possible outcomes of quantum measurements are physically realized in some "world" or universe.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/List_of_Farm_to_Market_Roads_in_Texas_(700–799)">List of Farm to Market Roads in Texas (700–799)</a></td>
      <td>Farm to Market Roads in Texas are owned and maintained by the Texas Department of Transportation (TxDOT).\n\n\n== FM 700 ==\nFarm to Market Road 700 (FM 700) is located in Howard County.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/NYC_Health_+_Hospitals">NYC Health + Hospitals</a></td>
      <td>NYC Health + Hospitals, officially the New York City Health and Hospitals Corporation (HHC), operates the public hospitals and clinics in New York City as a public benefit corporation. As of 2012, HHC is the largest municipal healthcare system in the United States with $6.7 billion in annual revenues, serving 1.4 million patients, including more than 475,000 uninsured city residents, providing services interpreted in more than 190 languages.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Competitor_Group">Competitor Group</a></td>
      <td>Competitor Group, Inc. (CGI) is a privately held, for-profit, sports marketing and management company based in Mira Mesa, San Diego, California.</td>
    </tr>
  </tbody>
</table><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='risk_factors'>Risk Factors</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>APRIA HEALTHCARE GROUP INC      ITEM 1A RISK FACTORS            Apria has identified the <font color="blue">following important factors</font> that could cause     actual  results  to  differ  <font color="blue">materially</font>  from  those  projected in any     forward-looking statements the <font color="blue">company may</font> make from time to time</td>
    </tr>
    <tr>
      <td>Collectibility  of Accounts Receivable—Apria’s failure to maintain its     controls and <font color="blue">processes over billing</font> and collecting or the <font color="blue">deterioration</font> of     the <font color="blue">financial condition</font> of its <font color="blue">payors could</font> have a <font color="blue"><font color="blue">significant</font> negative</font>     <font color="blue">impact on</font> its results of <font color="blue">operations</font> and <font color="blue">financial condition</font></td>
    </tr>
    <tr>
      <td>The  <font color="blue">collection</font>  of  <font color="blue">accounts</font>  receivable  is one of Apria’s most     <font color="blue">significant</font>  <font color="blue">challenges</font> and requires <font color="blue">constant focus</font> and <font color="blue">involvement by</font>     <font color="blue">management</font> and <font color="blue">ongoing enhancements</font> to information systems and billing     center operating procedures</td>
    </tr>
    <tr>
      <td>Further, some of Apria’s payors and/or patients     may experience <font color="blue">financial difficulties</font>, or <font color="blue">may otherwise</font> not pay <font color="blue">accounts</font>     receivable when due, resulting in increased write-offs</td>
    </tr>
    <tr>
      <td>There can be no     assurance that Apria will be able to maintain its controls and processes     over  billing  or  its <font color="blue">current levels</font> of <font color="blue">collectibility</font> and days sales     outstanding in <font color="blue">future periods</font></td>
    </tr>
    <tr>
      <td>If Apria is unable to <font color="blue">properly bill</font> and     collect its <font color="blue">accounts</font> receivable, its results will be <font color="blue">adversely affected</font></td>
    </tr>
    <tr>
      <td>Medicare/Medicaid Reimbursement Rates—Continued <font color="blue">reductions</font> in Medicare and     <font color="blue">Medicaid  </font><font color="blue">reimbursement</font>  <font color="blue">rates could</font> have a material adverse effect on     Apria’s results of <font color="blue">operations</font> and <font color="blue">financial condition</font></td>
    </tr>
    <tr>
      <td>There are a number of <font color="blue">provisions contained within recent</font>     <font color="blue">legislation</font> and proposed <font color="blue">legislation</font> that affect or may affect <font color="blue">reimbursement</font>     policies  for  items  and  <font color="blue">services provided by</font> Apria</td>
    </tr>
    <tr>
      <td>Certain of such     provisions reduced 2004 <font color="blue">net revenues</font> by <font color="blue">approximately</font> dlra15 million and 2005     <font color="blue">net revenues</font> by an <font color="blue">incremental</font> dlra27 million</td>
    </tr>
    <tr>
      <td>Other <font color="blue">reimbursement</font> changes in     the <font color="blue">legislation</font> are <font color="blue">still outstanding</font> and <font color="blue">will further reduce</font> Apria’s net     revenues</td>
    </tr>
    <tr>
      <td>In 2001, some states <font color="blue">began adopting alternative pricing</font>     <font color="blue">methodologies</font> for <font color="blue">certain drugs</font> and <font color="blue"><font color="blue">biologicals</font> under</font> the Medicaid program</td>
    </tr>
    <tr>
      <td>In a number of states, these changes have reduced the level of <font color="blue">reimbursement</font>     received by Apria without a <font color="blue">corresponding offset</font> or increase to compensate     for the <font color="blue">service costs incurred</font></td>
    </tr>
    <tr>
      <td>In several of those states, Apria elected to     <font color="blue">stop accepting new</font> Medicaid <font color="blue">patient referrals</font> for the <font color="blue">affected drugs</font> and     <font color="blue">biologicals</font></td>
    </tr>
    <tr>
      <td>Further, some states are considering other <font color="blue">reductions</font> in     Medicaid <font color="blue">reimbursement</font> as they work through their respective state’s budget     process</td>
    </tr>
    <tr>
      <td>”            <font color="blue"><font color="blue">Medicare and Medicaid</font> </font><font color="blue">payments accounted</font> for <font color="blue">approximately</font> 32prca and 7prca     of Apria’s 2005 <font color="blue">net revenues</font>, respectively</td>
    </tr>
    <tr>
      <td>Apria cannot be certain of the     ultimate  impact of all legislated and contemplated changes or provide     assurance to its investors that additional <font color="blue">reimbursement</font> <font color="blue">reductions</font> will not     be made</td>
    </tr>
    <tr>
      <td>Operating Systems and Controls—Apria’s failure to <font color="blue">successfully</font> implement     computer and other <font color="blue">system <font color="blue">modifications</font> designed</font> to <font color="blue">maximize <font color="blue">productivity</font></font>     could  ultimately have a <font color="blue"><font color="blue">significant</font> negative</font> <font color="blue">impact on</font> its results of     <font color="blue">operations</font> and <font color="blue">financial condition</font></td>
    </tr>
    <tr>
      <td>Apria’s <font color="blue">management</font> has identified a number of <font color="blue">areas throughout</font> its     <font color="blue">operations</font> where it intends to modify the <font color="blue">current processes</font> or systems in     order to attain a <font color="blue">higher level</font> of <font color="blue">productivity</font></td>
    </tr>
    <tr>
      <td>The <font color="blue">ultimate cost savings</font>     expected from the <font color="blue">successful design</font> and <font color="blue">implementation</font> of <font color="blue">such initiatives</font>     will  be <font color="blue">necessary</font> to <font color="blue">help offset</font> the impact of Medicare <font color="blue">reimbursement</font>     <font color="blue">reductions</font> and <font color="blue">continued downward pressure on pricing</font></td>
    </tr>
    <tr>
      <td>Apria’s failure to     <font color="blue">successfully</font>  implement  its  planned  system  <font color="blue">modifications</font> and other     <font color="blue">productivity</font> improvements could have a <font color="blue">significant</font> <font color="blue">impact on</font> its <font color="blue">operations</font>     and <font color="blue">financial condition</font></td>
    </tr>
    <tr>
      <td>Further, the <font color="blue">implementation</font> of these system changes     could  have  a <font color="blue">disruptive</font> effect on related <font color="blue">transaction</font> processing and     <font color="blue">operations</font></td>
    </tr>
    <tr>
      <td>Government  Regulation; Healthcare Reform—Non-compliance with laws and     <font color="blue"><font color="blue">regulations</font> applicable</font> to Apria’s business and future changes in those laws     and <font color="blue"><font color="blue">regulations</font> could</font> have a material adverse effect on Apria</td>
    </tr>
    <tr>
      <td>Apria is subject to <font color="blue">stringent laws</font> and <font color="blue"><font color="blue">regulations</font> at both</font> the federal     and state levels, requiring <font color="blue">compliance with burdensome</font> and <font color="blue">complex billing</font>,     <font color="blue">substantiation</font> and record-keeping requirements</td>
    </tr>
    <tr>
      <td><font color="blue">Financial </font><font color="blue">relationships</font>     between Apria and physicians and other <font color="blue">referral sources</font> are also subject to     <font color="blue">strict limitations</font></td>
    </tr>
    <tr>
      <td>In addition, strict licensing and <font color="blue">safety requirements</font>     apply  to  the  provision  of services, pharmaceuticals and equipment</td>
    </tr>
    <tr>
      <td><font color="blue">Violations </font>of these laws and <font color="blue"><font color="blue">regulations</font> could</font> subject Apria to severe     fines, <font color="blue">facility</font> shutdowns and possible exclusion from <font color="blue">participation</font> in     federal  healthcare programs such as <font color="blue">Medicare and Medicaid</font></td>
    </tr>
    <tr>
      <td><font color="blue">Government     </font>officials and the <font color="blue">public will continue</font> to <font color="blue">debate healthcare reform</font></td>
    </tr>
    <tr>
      <td><font color="blue">Changes     </font>in healthcare law, new <font color="blue">interpretations</font> of existing laws, or changes in     payment <font color="blue">methodology</font> may have a dramatic effect on Apria’s business and     results of <font color="blue">operations</font></td>
    </tr>
    <tr>
      <td>Pricing  Pressures—Apria  believes  that  <font color="blue">continued pressure</font> to reduce     <font color="blue">healthcare costs could</font> have a material adverse effect on the company</td>
    </tr>
    <tr>
      <td>The <font color="blue">current market continues</font> to <font color="blue">exert pressure on healthcare companies</font>     to <font color="blue">reduce healthcare costs</font>, resulting in <font color="blue">reduced margins</font> for <font color="blue">home healthcare</font>     <font color="blue">providers such as</font> Apria</td>
    </tr>
    <tr>
      <td>Larger group <font color="blue">purchasing <font color="blue">organizations</font></font> and supplier     groups exert additional pricing pressure on <font color="blue">home healthcare</font> providers</td>
    </tr>
    <tr>
      <td><font color="blue">These     </font>include managed care <font color="blue">organizations</font>, which control an increasing portion of     the <font color="blue">healthcare economy</font></td>
    </tr>
    <tr>
      <td>Apria has a number of <font color="blue">contractual arrangements with</font>     managed  care  <font color="blue">organizations</font> and other parties, although no individual     <font color="blue">arrangement accounted</font> for more than 9prca of Apria’s <font color="blue">net revenues</font> in 2005</td>
    </tr>
    <tr>
      <td>The segment of the <font color="blue">healthcare market</font> in which Apria operates is highly     <font color="blue">competitive</font></td>
    </tr>
    <tr>
      <td>In each of its service lines, there are a number of national     providers  and  numerous  regional and <font color="blue">local providers</font></td>
    </tr>
    <tr>
      <td>Other types of     <font color="blue">healthcare providers</font>, including <font color="blue">industrial gas manufacturers</font>, individual     hospitals and hospital systems, home health agencies and <font color="blue">health maintenance</font>     <font color="blue">organizations</font> have entered, and <font color="blue">may continue</font> to enter the market to compete     with Apria’s <font color="blue">various service lines</font></td>
    </tr>
    <tr>
      <td>Some of these <font color="blue">competitors</font> have access to     <font color="blue">significant</font>ly greater financial and marketing resources than Apria</td>
    </tr>
  </tbody>
</table>